Skip to content
Nonprofiteer
← BBG ADVANCED THERAPIES

Form 990 for tax year 2023

Filed by BBG ADVANCED THERAPIES.

Totals

Total revenue
$5,040,198
Total expenses
$15,033,401
Contributions and grants received
$0
Grants paid
$0
Program service revenue
$5,018,815
Investment income
$0
Other revenue
$21,383
Total assets, end of year
$18,815,048
Total liabilities, end of year
$10,920,765
Net assets or fund balances, end of year
$7,894,283
Program services expenses (Part IX)
$10,041,362
Management and general expenses
$4,992,039
Fundraising expenses
$0
Program service expenses (Part III)
$10,041,362

Program services were 66.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 2a · Program service revenue: BIOMANUFACTURING SERVICE FEES

    total $5,018,815 · related or exempt $5,018,815

  • 2f · All other program service revenue

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 6c · Rental income or loss

    real property $0 · personal property $0

  • 7c · Gain or loss

    securities $0 · other assets $0

  • 11a · Other revenue: PURCHASE REBATES

    total $21,383 · related or exempt $21,383 · unrelated business $0 · excluded $0

  • 11d · All other revenue

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 11e · Other revenue, total

    $21,383

Functional expenses

Part IX, the statement of functional expenses.

  • 5 · Compensation of officers, directors and key employees

    total $230,644 · program services $230,644

  • 7 · Other salaries and wages

    total $2,910,572 · program services $2,910,572

  • 8 · Pension plan contributions

    total $154,220 · program services $154,220

  • 9 · Other employee benefits

    total $297,193 · program services $297,193

  • 10 · Payroll taxes

    total $224,354 · program services $224,354

  • 11g · Fees: other

    total $221,702 · program services $221,702 · management and general $0 · fundraising $0

  • 12 · Advertising and promotion

    total $16 · program services $16

  • 13 · Office expenses

    total $262,652 · program services $262,652

  • 14 · Information technology

    total $26,963 · program services $26,963

  • 16 · Occupancy

    total $1,030,423 · program services $1,030,423

  • 17 · Travel

    total $87,224 · program services $87,224

  • 19 · Conferences, conventions and meetings

    total $12,457 · program services $12,457

  • 20 · Interest

    total $149,952 · program services $149,952

  • 22 · Depreciation, depletion and amortization

    total $1,673,927 · program services $1,673,927

  • 23 · Insurance

    total $9,089 · management and general $9,089

  • 24a · Other expenses: SUPPORT & ADMINISTRATIVE FEE

    total $4,982,950 · program services $0 · management and general $4,982,950 · fundraising $0

  • 24b · Other expenses: TESTING EXPENSES & SUPPLIES

    total $1,770,872 · program services $1,770,872 · management and general $0 · fundraising $0

  • 24c · Other expenses: EQUIPMENT MAINTENANCE

    total $463,324 · program services $463,324 · management and general $0 · fundraising $0

  • 24d · Other expenses: BAD DEBTS

    total $267,162 · program services $267,162 · management and general $0 · fundraising $0

  • 24e · All other expenses

    total $257,705 · program services $257,705 · management and general $0 · fundraising $0

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $138,260 · end of year $154,464

  • 4 · Accounts receivable

    beginning of year $2,067,816 · end of year $991,756

  • 5 · Loans and receivables from officers and key people

    beginning of year $0 · end of year $0

  • 6 · Loans and receivables from disqualified persons

    beginning of year $0 · end of year $0

  • 8 · Inventories for sale or use

    beginning of year $1,064,171 · end of year $1,279,936

  • 9 · Prepaid expenses and deferred charges

    beginning of year $121,668 · end of year $113,427

  • 10a · Land, buildings and equipment: cost or other basis

    $16,909,850

  • 10b · Land, buildings and equipment: accumulated depreciation

    $5,891,088

  • 10c · Land, buildings and equipment, net

    beginning of year $12,617,843 · end of year $11,018,762

  • 12 · Investments: other securities

    beginning of year $0

  • 13 · Investments: program-related

    beginning of year $0

  • 15 · Other assets

    beginning of year $5,817,384 · end of year $5,256,703

  • 17 · Accounts payable and accrued expenses

    beginning of year $2,614,994 · end of year $593,174

  • 22 · Loans and payables to officers and key people

    beginning of year $0 · end of year $0

  • 23 · Secured mortgages and notes payable

    beginning of year $5,836,922 · end of year $4,159,848

  • 25 · Other liabilities

    beginning of year $6,341,139 · end of year $6,167,743

  • 27 · Net assets without donor restrictions

    beginning of year $7,034,087 · end of year $7,894,283

Mission and programs · 2023

Mission

GENCURE IS ORGANIZED TO FOCUS ON REGENERATIVE MEDICINE AND THE UTILIZATION OF THE POWER OF HUMAN CELLS AND TISSUE TO ENHANCE LIVES AND ENABLE CLINICAL ADVANCEMENTS.

Activities or mission (Part I)

GenCure enables progress in the field of advanced therapies (also known as cell & gene therapies) by offering process and analytical (CONTINUED ON SCHEDULE O)

  • GenCure enables progress in the field of advanced therapies (also known as cell & gene therapies) by offering process and analytical development, bioproduction, in-process and release testing, while leveraging a unified quality management system. We partner with our users with the end goal of clinical development in mind, supporting the development of therapies often originating from academic institutions. GenCure's clinical-scale facility opened in March 2020, The bioproduction space is compliant with FDA regulations, EU Annex 1 and PMDA (Grade A, B, C, D). Cleanrooms are sized for a wide range of production volumes and multi-product capabilities, which can meet the need of a variety of research programs. This facility includes 6,700 square feet of cleanroom production space, a 2,500-square-foot development lab, along with office and meeting space. (Continued on Schedule O)

    Expenses $10,041,362 · Revenue $5,040,198

As filed on the 2023 return.

Listed in Part VII

  • BIOBRIDGE GLOBAL

    SOLE MEMBER

    Total calculated
    $0
    Hours/week
    1 + 3 related

  • GEOFFREY KINDT

    General Manager, Biomanufacturing (effective 01/29/23)

    Total calculated
    $301,303
    From this org
    $211,559
    From related orgs
    $47,671
    Other
    $42,073
    Hours/week
    50 + 50 related

    Schedule J breakdown matched by us

    Base
    $208,882 + $24,961 related
    Bonus
    $0 + $22,539 related
    Other
    $2,677 + $171 related
    Deferred
    $11,183 + $1,698 related
    Nontaxable benefits
    $28,956 + $236 related
    Filer's total
    $251,698 + $49,605 related

  • AMANDA WHITELONIS

    SR. DIRECTOR, PROGRAM MANAGEMENT (through 11/05/23)

    Total calculated
    $185,742
    From this org
    $147,680
    From related orgs
    $18,924
    Other
    $19,138
    Hours/week
    50 + 50 related

    Schedule J breakdown matched by us

    Base
    $133,563 + $18,624 related
    Bonus
    $13,122
    Other
    $995 + $299 related
    Deferred
    $8,913 + $1,139 related
    Nontaxable benefits
    $836 + $8,250 related
    Filer's total
    $157,429 + $28,313 related

  • CHRISTIE MALONE

    SR. DIRECTOR,CUSTOM SOLUTIONS & SALES SUP

    Total calculated
    $244,595
    From this org
    $187,962
    From related orgs
    $22,575
    Other
    $34,058
    Hours/week
    25 + 25 related

    Schedule J breakdown matched by us

    Base
    $167,113 + $22,165 related
    Bonus
    $18,848
    Other
    $2,002 + $410 related
    Deferred
    $11,681 + $1,133 related
    Nontaxable benefits
    $4,326 + $16,919 related
    Filer's total
    $203,969 + $40,627 related

  • MARI LANE SALMI

    SR. DIRECTOR, PROCESS DEV & CELL THERAPIES

    Total calculated
    $223,259
    From this org
    $186,532
    From related orgs
    $0
    Other
    $36,727
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $167,740
    Bonus
    $16,638
    Other
    $2,154
    Deferred
    $4,941
    Nontaxable benefits
    $31,786
    Filer's total
    $223,259

  • MILTON MASAYUKI POLLARD

    VP, GENCURE OPERATIONS

    Total calculated
    $288,656
    From this org
    $253,559
    From related orgs
    $0
    Other
    $35,097
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $225,505
    Bonus
    $24,093
    Other
    $3,961
    Deferred
    $13,420
    Nontaxable benefits
    $21,678
    Filer's total
    $288,656

  • ROGELIO ZAMILPA

    SR. DIRECTOR, MFG SCIENCES & TECHNOLOGY

    Total calculated
    $241,163
    From this org
    $209,903
    From related orgs
    $0
    Other
    $31,260
    Hours/week
    50

    Schedule J breakdown matched by us

    Base
    $183,046
    Bonus
    $24,702
    Other
    $2,155
    Deferred
    $12,892
    Nontaxable benefits
    $18,367
    Filer's total
    $241,163

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

Schedule J, Part I, Line 3 Arrangement used to establish the top management official's compensation
THE ORGANIZATION RELIED ON BIOBRIDGE GLOBAL'S PROCESS THAT USED ONE OR MORE OF THE METHODS LISTED IN SCHEDULE J, PART I, LINE 3 TO ESTABLISH THE TOP MANAGEMENT OFFICIAL'S COMPENSATION.
Schedule J, Part I, Line 6a Compensation contingent on net earnings of the organization
THE ORGANIZATION RELIED ON BIOBRIDGE GLOBAL'S PROCESS OF DETERMINING THE COMPENSATION CONTINGENT ON THE ORGANIZATION'S EARNINGS. THE PROCESS IS DISCLOSED ON THEIR FORM 990.
Schedule J, Part I, Line 6b Compensation contingent on net earnings of a related organization
THE ORGANIZATION RELIED ON BIOBRIDGE GLOBAL'S PROCESS OF DETERMINING THE COMPENSATION CONTINGENT ON THE ORGANIZATION'S EARNINGS. THE PROCESS IS DISCLOSED ON THEIR FORM 990.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Provenance

Return type
form_990
Tax year
2023
Filed
15 November 2024
IRS schema version
2023v5.1
Source object
202403199349319060

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.